The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy

Author(s): Yong Zhang, Zhen Tian, Jiajia Yuan, Chang Liu, Hong li Liu, Si Qi Ma, Bin Li*

Journal Name: Current Gene Therapy

Volume 17 , Issue 4 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Introduction: Leber's Optic Hereditary Neuropathy (LHON) is a common cause of teenaged blindness in both eyes for which there is currently no effective treatment. In 1871, the German ophthalmologist Theodor Leber was the first to describe the clinical characteristics of his namesake disease, and through unremitting efforts over the past 100 years, researchers have continued to increase their understanding of LHON. In recent years, using gene therapy, several groups have obtained breakthroughs in the treatment of the disease.

Conclusion: In this article, we will review the challenging journey that researchers faced towards our current understanding of LHON, and describe the transition of gene therapy research for LHON from the bench to bedside.

Keywords: Leber's optic hereditary neuropathy, Gene therapy, Translational medicine, Mitochondrial disease, MT-ND4, Allotopic expression technology.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 04 January, 2018
Page: [320 - 326]
Pages: 7
DOI: 10.2174/1566523218666171129204926

Article Metrics

PDF: 68
HTML: 12